{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:04:08Z","timestamp":1780448648288,"version":"3.54.1"},"reference-count":54,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"DOI":"10.3171\/2026.2.focus251155","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:57Z","timestamp":1779840057000},"page":"E13","source":"Crossref","is-referenced-by-count":0,"title":["Rethinking the role of surgery and radiotherapy in BRAF-mutant papillary craniopharyngioma: a position statement from the neurosurgical perspective"],"prefix":"10.3171","volume":"60","author":[{"given":"Tareq A.","family":"Juratli","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University Hospital Carl Gustav Carus, TU Dresden, Germany;"},{"name":"Laboratory of Translational Neuro-Oncology, Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts;"},{"name":"National Center for Tumor Diseases (NCT), NCT\/UCC Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Prieto","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Puerta de Hierro University Hospital, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Fujio","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and National Center for Neurological Disorders, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China;"},{"name":"Neuroendocrine Unit, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilker Y.","family":"Ey\u00fcpoglu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Carl Gustav Carus, TU Dresden, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Clusmann","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, RWTH Aachen University, Aachen;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Rohde","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Medical Center G\u00f6ttingen;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erdem","family":"G\u00fcresir","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Leipzig;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Sure","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Spine Surgery, University Hospital Essen;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Erol","family":"Sandalcioglu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Otto-von-Guericke University, Magdeburg;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Etminan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital and Medical Faculty Mannheim, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Amini","sequence":"additional","affiliation":[{"name":"Mazandaran University of Medical Sciences, Sari, Iran;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Jouanneau","sequence":"additional","affiliation":[{"name":"Skull Base and Pituitary Unit, Department of Neurosurgery B, Neurological Hospital Pierre-Wertheimer, Bron;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Fava","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Lariboisi\u00e8re Hospital, Assistance Publique - Hopitaux de Paris, University of Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyang","family":"Hua","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and National Center for Neurological Disorders, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidan","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and National Center for Neurological Disorders, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeeva","family":"Jeyaretna","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Oxford University Hospitals NHS Trust, Oxford;"},{"name":"Nuffield Department of Surgical Sciences, University of Oxford;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Cardiff and Vale University, Cardiff;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk","family":"Borg","sequence":"additional","affiliation":[{"name":"Victor Horsley Department of Neurosurgery, National Hospital for Neurology and Neurosurgery, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulam","family":"Zilani","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Neuroscience Centre, Beaumont Hospital Dublin, Ireland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Horiguchi","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Chiba University Hospital, Chiba;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Tosaka","sequence":"additional","affiliation":[{"name":"Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohiko","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kurume University School of Medicine, Kurume, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P.","family":"Sheehan","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Virginia, Charlottesville, Virginia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen A.","family":"Shih","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Massachusetts General Hospital\/Mass General Brigham, Harvard Medical School, Boston;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Cahill","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Neuro-Oncology, Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts;"},{"name":"Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Pascual","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, La Princesa University Hospital, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin H.","family":"Mak","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Queen Elizabeth Hospital, Hong Kong;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and National Center for Neurological Disorders, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China;"},{"name":"Shanghai Key Laboratory of Brain Function Restoration and Neural Regeneration, Shanghai;"},{"name":"Neurosurgical Institute of Fudan University, Shanghai, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songbai","family":"Gui","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi Maria","family":"Cavallo","sequence":"additional","affiliation":[{"name":"Department of Neurosciences and Reproductive and Odontostomatological Sciences, Division of Neurosurgery, Universit\u00e0 degli Studi di Napoli Federico II, Naples, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Tatagiba","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Eberhard-Karls-Universit\u00e4t T\u00fcbingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Froelich","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Lariboisi\u00e8re Hospital, Assistance Publique - Hopitaux de Paris, University of Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore H.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Mount Sinai Hospital, Icahn School of Medicine, New York, New York;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred G.","family":"Barker","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla K.","family":"Brastianos","sequence":"additional","affiliation":[{"name":"Divisions of Neuro-Oncology and Hematology\/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1","series-title":"Handb Clin Neurol","first-page":"75","article-title":"Craniopharyngiomas primarily affecting the hypothalamus","volume":"181","author":"Pascual JM","year":"2021","unstructured":"Pascual JM, Prieto R, Rosdolsky M. Craniopharyngiomas primarily affecting the hypothalamus. Handb Clin Neurol. 2021;181:75\u2013115. doi:10.1016\/B978-0-12-820683-6.00007-5"},{"issue":"1","key":"b2","series-title":"Neurosurg Rev","first-page":"375","article-title":"Strictly third ventricle craniopharyngiomas: pathological verification, anatomo-clinical characterization and surgical results from a comprehensive overview of 245 cases","volume":"45","author":"Prieto R","year":"2022","unstructured":"Prieto R, Barrios L, Pascual JM. Strictly third ventricle craniopharyngiomas: pathological verification, anatomo-clinical characterization and surgical results from a comprehensive overview of 245 cases. Neurosurg Rev. 2022;45(1):375\u2013394. doi:10.1007\/s10143-021-01615-0"},{"issue":"2","key":"b3","series-title":"Neuroendocrinology","first-page":"196","article-title":"Craniopharyngiomas in the elderly: the crucial influence of tumor topography on surgical risk assessment","volume":"112","author":"Pascual JM","year":"2022","unstructured":"Pascual JM, Prieto R. Craniopharyngiomas in the elderly: the crucial influence of tumor topography on surgical risk assessment. Neuroendocrinology. 2022;112(2):196\u2013200. doi:10.1159\/000516172"},{"issue":"10","key":"b4","series-title":"Neuroendocrinology","first-page":"941","article-title":"Papillary craniopharyngioma: a type of tumor primarily impairing the hypothalamus - a comprehensive anatomo-clinical characterization of 350 well-described cases","volume":"112","author":"Prieto R","year":"2022","unstructured":"Prieto R, Barrios L, Pascual JM. Papillary craniopharyngioma: a type of tumor primarily impairing the hypothalamus - a comprehensive anatomo-clinical characterization of 350 well-described cases. Neuroendocrinology. 2022;112(10):941\u2013965. doi:10.1159\/000521652"},{"issue":"2","key":"b5","series-title":"N Engl J Med","first-page":"118","article-title":"BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas","volume":"389","author":"Brastianos PK","year":"2023","unstructured":"Brastianos PK, Twohy E, Geyer S,  BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med. 2023;389(2):118\u2013126. doi:10.1056\/NEJMoa2213329"},{"issue":"2","key":"b6","series-title":"Eur J Endocrinol","first-page":"251","article-title":"BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study","volume":"191","author":"De Alcubierre D","year":"2024","unstructured":"De Alcubierre D, Gkasdaris G, Mordrel M,  BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study. Eur J Endocrinol. 2024;191(2):251\u2013261. doi:10.1093\/ejendo\/lvae091"},{"issue":"2","key":"b7","series-title":"Endocr Rev","first-page":"151","article-title":"Papillary craniopharyngioma: an integrative and comprehensive review","volume":"46","author":"Prieto R","year":"2025","unstructured":"Prieto R, Juratli TA, Bander ED,  Papillary craniopharyngioma: an integrative and comprehensive review. Endocr Rev. 2025;46(2):151\u2013213. doi:10.1210\/endrev\/bnae028"},{"issue":"5","key":"b8","series-title":"Neurol Med Chir (Tokyo)","first-page":"217","article-title":"Prospects of BRAF\/MEK inhibitor therapy in papillary craniopharyngiomas with the BRAF V600E mutation: a scoping review","volume":"65","author":"Fujio S","year":"2025","unstructured":"Fujio S, Ilmansyah R, Makino R,  Prospects of BRAF\/MEK inhibitor therapy in papillary craniopharyngiomas with the BRAF V600E mutation: a scoping review. Neurol Med Chir (Tokyo). 2025;65(5):217\u2013229. doi:10.2176\/jns-nmc.2024-0246"},{"issue":"4","key":"b9","series-title":"Mol Ther Oncol","first-page":"201085","article-title":"Efficacy and safety of BRAF-MEK inhibitors in treatment of Chinese patients with papillary craniopharyngioma: a retrospective cohort study","volume":"33","author":"Han R","year":"2025","unstructured":"Han R, Yan X, Yao B,  Efficacy and safety of BRAF-MEK inhibitors in treatment of Chinese patients with papillary craniopharyngioma: a retrospective cohort study. Mol Ther Oncol. 2025;33(4):201085. doi:10.1016\/j.omton.2025.201085"},{"issue":"6","key":"b10","series-title":"Neurosurg Focus","first-page":"E13","article-title":"Craniopharyngioma adherence: a comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors","volume":"41","author":"Prieto R","year":"2016","unstructured":"Prieto R, Pascual JM, Rosdolsky M,  Craniopharyngioma adherence: a comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors. Neurosurg Focus. 2016;41(6):E13. doi:10.3171\/2016.9.FOCUS16304"},{"key":"b11","series-title":"World Neurosurg","first-page":"e404","article-title":"Preoperative assessment of craniopharyngioma adherence: magnetic resonance imaging findings correlated with the severity of tumor attachment to the hypothalamus","volume":"110","author":"Prieto R","year":"2018","unstructured":"Prieto R, Pascual JM, Rosdolsky M, Barrios L. Preoperative assessment of craniopharyngioma adherence: magnetic resonance imaging findings correlated with the severity of tumor attachment to the hypothalamus. World Neurosurg. 2018;110:e404\u2013e426. doi:10.1016\/j.wneu.2017.11.012"},{"issue":"2","key":"b12","series-title":"Neurosurg Rev","first-page":"453","article-title":"Craniopharyngioma adherence: a reappraisal of the evidence","volume":"43","author":"Prieto R","year":"2020","unstructured":"Prieto R, Pascual JM, Hofecker V,  Craniopharyngioma adherence: a reappraisal of the evidence. Neurosurg Rev. 2020;43(2):453\u2013472. doi:10.1007\/s10143-018-1010-9"},{"issue":"1","key":"b13","series-title":"J Neurol Surg B Skull Base","first-page":"1","article-title":"The RAPID Consortium: a platform for clinical and translational pituitary tumor research","volume":"85","author":"Karsy M","year":"2024","unstructured":"Karsy M, Kshettry V, Gardner P,  The RAPID Consortium: a platform for clinical and translational pituitary tumor research. J Neurol Surg B Skull Base. 2024;85(1):1\u20138. doi:10.1055\/a-1978-9380"},{"issue":"6","key":"b14","series-title":"Neurosurg Focus","first-page":"E15","article-title":"A quantitative analysis of craniopharyngioma cyst expansion during and after radiation therapy and surgical implications","volume":"41","author":"Lamiman K","year":"2016","unstructured":"Lamiman K, Wong KK, Tamrazi B,  A quantitative analysis of craniopharyngioma cyst expansion during and after radiation therapy and surgical implications. Neurosurg Focus. 2016;41(6):E15. doi:10.3171\/2016.9.FOCUS16298"},{"issue":"6","key":"b15","series-title":"BMJ Open","first-page":"e046043","article-title":"Proton therapy for craniopharyngioma in adults: a protocol for systematic review and meta-analysis","volume":"11","author":"Li P","year":"2021","unstructured":"Li P, Wang J, Axier A,  Proton therapy for craniopharyngioma in adults: a protocol for systematic review and meta-analysis. BMJ Open. 2021;11(6):e046043. doi:10.1136\/bmjopen-2020-046043"},{"issue":"11","key":"b16","series-title":"AJNR Am J Neuroradiol","first-page":"2073","article-title":"Topographic diagnosis of craniopharyngiomas: the accuracy of MRI findings observed on conventional T1 and T2 images","volume":"38","author":"Prieto R","year":"2017","unstructured":"Prieto R, Pascual JM, Barrios L. Topographic diagnosis of craniopharyngiomas: the accuracy of MRI findings observed on conventional T1 and T2 images. AJNR Am J Neuroradiol. 2017;38(11):2073\u20132080. doi:10.3174\/ajnr.A5361"},{"issue":"2","key":"b17","series-title":"Neurosurgery","first-page":"204","article-title":"A clinical rule for preoperative prediction of BRAF mutation status in craniopharyngiomas","volume":"85","author":"Fujio S","year":"2019","unstructured":"Fujio S, Juratli TA, Arita K,  A clinical rule for preoperative prediction of BRAF mutation status in craniopharyngiomas. Neurosurgery. 2019;85(2):204\u2013210. doi:10.1093\/neuros\/nyy569"},{"issue":"5","key":"b18","series-title":"J Neuropathol Exp Neurol","first-page":"330","article-title":"Basal recess in third ventricle tumors: a pathological feature defining a clinical-topographical subpopulation of papillary craniopharyngiomas","volume":"81","author":"Pascual JM","year":"2022","unstructured":"Pascual JM, Prieto R, Carrasco R, Barrios L. Basal recess in third ventricle tumors: a pathological feature defining a clinical-topographical subpopulation of papillary craniopharyngiomas. J Neuropathol Exp Neurol. 2022;81(5):330\u2013343. doi:10.1093\/jnen\/nlac020"},{"issue":"9","key":"b19","series-title":"AJNR Am J Neuroradiol","first-page":"1333","article-title":"Duct-like recess in the infundibular portion of third ventricle craniopharyngiomas: an MRI sign identifying the papillary type","volume":"43","author":"Pascual JM","year":"2022","unstructured":"Pascual JM, Carrasco R, Barrios L, Prieto R. Duct-like recess in the infundibular portion of third ventricle craniopharyngiomas: an MRI sign identifying the papillary type. AJNR Am J Neuroradiol. 2022;43(9):1333\u20131340. doi:10.3174\/ajnr.A7602"},{"issue":"2","key":"b20","series-title":"J Neurosurg","first-page":"381","article-title":"Displacement of mammillary bodies by craniopharyngiomas involving the third ventricle: surgical-MRI correlation and use in topographical diagnosis","volume":"119","author":"Pascual JM","year":"2013","unstructured":"Pascual JM, Prieto R, Carrasco R, Barrios L. Displacement of mammillary bodies by craniopharyngiomas involving the third ventricle: surgical-MRI correlation and use in topographical diagnosis. J Neurosurg. 2013;119(2):381\u2013405. doi:10.3171\/2013.1.JNS111722"},{"issue":"5","key":"b21","series-title":"Jpn J Clin Oncol","first-page":"378","article-title":"Optic tract edema in craniopharyngioma as a predictor of BRAFV600E mutation presence","volume":"53","author":"Taguchi A","year":"2023","unstructured":"Taguchi A, Kinoshita Y, Kojima M,  Optic tract edema in craniopharyngioma as a predictor of BRAFV600E mutation presence. Jpn J Clin Oncol. 2023;53(5):378\u2013385. doi:10.1093\/jjco\/hyad003"},{"issue":"3","key":"b22","series-title":"Clin Nucl Med","first-page":"245","article-title":"High 18F-FDG uptake in a papillary craniopharyngioma of the third ventricle","volume":"48","author":"Kaida H","year":"2023","unstructured":"Kaida H, Matsukubo Y, Im SW, Kashiwagi N, Ishii K. High 18F-FDG uptake in a papillary craniopharyngioma of the third ventricle. Clin Nucl Med. 2023;48(3):245\u2013247. doi:10.1097\/RLU.0000000000004562"},{"key":"b23","series-title":"World Neurosurg","first-page":"591","article-title":"Preoperative evaluation of sellar and parasellar macrolesions by [18F]fluorodeoxyglucose positron emission tomography","volume":"103","author":"Tosaka M","year":"2017","unstructured":"Tosaka M, Higuchi T, Horiguchi K,  Preoperative evaluation of sellar and parasellar macrolesions by [18F]fluorodeoxyglucose positron emission tomography. World Neurosurg. 2017;103:591\u2013599. doi:10.1016\/j.wneu.2017.04.032"},{"issue":"1","key":"b24","series-title":"BMC Neurol","first-page":"6","article-title":"Noninvasive molecular diagnosis of craniopharyngioma with MRI-based radiomics approach","volume":"19","author":"Chen X","year":"2019","unstructured":"Chen X, Tong Y, Shi Z,  Noninvasive molecular diagnosis of craniopharyngioma with MRI-based radiomics approach. BMC Neurol. 2019;19(1):6. doi:10.1186\/s12883-018-1216-z"},{"issue":"1","key":"b25","series-title":"Radiat Oncol","first-page":"161","article-title":"Proton beam therapy for craniopharyngioma: a systematic review and meta-analysis","volume":"19","author":"Li Z","year":"2024","unstructured":"Li Z, Li Q, Tian H,  Proton beam therapy for craniopharyngioma: a systematic review and meta-analysis. Radiat Oncol. 2024;19(1):161. doi:10.1186\/s13014-024-02556-w"},{"issue":"5","key":"b26","series-title":"Pituitary","first-page":"103","article-title":"Efficacy and safety of proton therapy and photon therapy for patients with craniopharyngioma: a systematic review and meta-analysis","volume":"28","author":"Pan LS","year":"2025","unstructured":"Pan LS, Zhang J, Xiong YT, Zhan JB, Wang QY, Hong T. Efficacy and safety of proton therapy and photon therapy for patients with craniopharyngioma: a systematic review and meta-analysis. Pituitary. 2025;28(5):103. doi:10.1007\/s11102-025-01578-1"},{"issue":"5","key":"b27","series-title":"Nat Med","first-page":"1103","article-title":"Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial","volume":"29","author":"Subbiah V","year":"2023","unstructured":"Subbiah V, Kreitman RJ, Wainberg ZA,  Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial. Nat Med. 2023;29(5):1103\u20131112. doi:10.1038\/s41591-023-02321-8"},{"key":"b1","series-title":"Handb Clin Neurol","first-page":"75","article-title":"Craniopharyngiomas primarily affecting the hypothalamus","volume":"181","author":"Pascual JM","year":"2021","unstructured":"Pascual JM, Prieto R, Rosdolsky M. Craniopharyngiomas primarily affecting the hypothalamus. Handb Clin Neurol. 2021;181:75\u2013115. doi:10.1016\/B978-0-12-820683-6.00007-5"},{"issue":"1","key":"b2","series-title":"Neurosurg Rev","first-page":"375","article-title":"Strictly third ventricle craniopharyngiomas: pathological verification, anatomo-clinical characterization and surgical results from a comprehensive overview of 245 cases","volume":"45","author":"Prieto R","year":"2022","unstructured":"Prieto R, Barrios L, Pascual JM. Strictly third ventricle craniopharyngiomas: pathological verification, anatomo-clinical characterization and surgical results from a comprehensive overview of 245 cases. Neurosurg Rev. 2022;45(1):375\u2013394. doi:10.1007\/s10143-021-01615-0"},{"issue":"2","key":"b3","series-title":"Neuroendocrinology","first-page":"196","article-title":"Craniopharyngiomas in the elderly: the crucial influence of tumor topography on surgical risk assessment","volume":"112","author":"Pascual JM","year":"2022","unstructured":"Pascual JM, Prieto R. Craniopharyngiomas in the elderly: the crucial influence of tumor topography on surgical risk assessment. Neuroendocrinology. 2022;112(2):196\u2013200. doi:10.1159\/000516172"},{"issue":"10","key":"b4","series-title":"Neuroendocrinology","first-page":"941","article-title":"Papillary craniopharyngioma: a type of tumor primarily impairing the hypothalamus - a comprehensive anatomo-clinical characterization of 350 well-described cases","volume":"112","author":"Prieto R","year":"2022","unstructured":"Prieto R, Barrios L, Pascual JM. Papillary craniopharyngioma: a type of tumor primarily impairing the hypothalamus - a comprehensive anatomo-clinical characterization of 350 well-described cases. Neuroendocrinology. 2022;112(10):941\u2013965. doi:10.1159\/000521652"},{"issue":"2","key":"b5","series-title":"N Engl J Med","first-page":"118","article-title":"BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas","volume":"389","author":"Brastianos PK","year":"2023","unstructured":"Brastianos PK, Twohy E, Geyer S,  BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med. 2023;389(2):118\u2013126. doi:10.1056\/NEJMoa2213329"},{"issue":"2","key":"b6","series-title":"Eur J Endocrinol","first-page":"251","article-title":"BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study","volume":"191","author":"De Alcubierre D","year":"2024","unstructured":"De Alcubierre D, Gkasdaris G, Mordrel M,  BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study. Eur J Endocrinol. 2024;191(2):251\u2013261. doi:10.1093\/ejendo\/lvae091"},{"issue":"2","key":"b7","series-title":"Endocr Rev","first-page":"151","article-title":"Papillary craniopharyngioma: an integrative and comprehensive review","volume":"46","author":"Prieto R","year":"2025","unstructured":"Prieto R, Juratli TA, Bander ED,  Papillary craniopharyngioma: an integrative and comprehensive review. Endocr Rev. 2025;46(2):151\u2013213. doi:10.1210\/endrev\/bnae028"},{"issue":"5","key":"b8","series-title":"Neurol Med Chir (Tokyo)","first-page":"217","article-title":"Prospects of BRAF\/MEK inhibitor therapy in papillary craniopharyngiomas with the BRAF V600E mutation: a scoping review","volume":"65","author":"Fujio S","year":"2025","unstructured":"Fujio S, Ilmansyah R, Makino R,  Prospects of BRAF\/MEK inhibitor therapy in papillary craniopharyngiomas with the BRAF V600E mutation: a scoping review. Neurol Med Chir (Tokyo). 2025;65(5):217\u2013229. doi:10.2176\/jns-nmc.2024-0246"},{"issue":"4","key":"b9","series-title":"Mol Ther Oncol","first-page":"201085","article-title":"Efficacy and safety of BRAF-MEK inhibitors in treatment of Chinese patients with papillary craniopharyngioma: a retrospective cohort study","volume":"33","author":"Han R","year":"2025","unstructured":"Han R, Yan X, Yao B,  Efficacy and safety of BRAF-MEK inhibitors in treatment of Chinese patients with papillary craniopharyngioma: a retrospective cohort study. Mol Ther Oncol. 2025;33(4):201085. doi:10.1016\/j.omton.2025.201085"},{"issue":"6","key":"b10","series-title":"Neurosurg Focus","first-page":"E13","article-title":"Craniopharyngioma adherence: a comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors","volume":"41","author":"Prieto R","year":"2016","unstructured":"Prieto R, Pascual JM, Rosdolsky M,  Craniopharyngioma adherence: a comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors. Neurosurg Focus. 2016;41(6):E13. doi:10.3171\/2016.9.FOCUS16304"},{"key":"b11","series-title":"World Neurosurg","first-page":"e404","article-title":"Preoperative assessment of craniopharyngioma adherence: magnetic resonance imaging findings correlated with the severity of tumor attachment to the hypothalamus","volume":"110","author":"Prieto R","year":"2018","unstructured":"Prieto R, Pascual JM, Rosdolsky M, Barrios L. Preoperative assessment of craniopharyngioma adherence: magnetic resonance imaging findings correlated with the severity of tumor attachment to the hypothalamus. World Neurosurg. 2018;110:e404\u2013e426. doi:10.1016\/j.wneu.2017.11.012"},{"issue":"2","key":"b12","series-title":"Neurosurg Rev","first-page":"453","article-title":"Craniopharyngioma adherence: a reappraisal of the evidence","volume":"43","author":"Prieto R","year":"2020","unstructured":"Prieto R, Pascual JM, Hofecker V,  Craniopharyngioma adherence: a reappraisal of the evidence. Neurosurg Rev. 2020;43(2):453\u2013472. doi:10.1007\/s10143-018-1010-9"},{"issue":"1","key":"b13","series-title":"J Neurol Surg B Skull Base","first-page":"1","article-title":"The RAPID Consortium: a platform for clinical and translational pituitary tumor research","volume":"85","author":"Karsy M","year":"2024","unstructured":"Karsy M, Kshettry V, Gardner P,  The RAPID Consortium: a platform for clinical and translational pituitary tumor research. J Neurol Surg B Skull Base. 2024;85(1):1\u20138. doi:10.1055\/a-1978-9380"},{"issue":"6","key":"b14","series-title":"Neurosurg Focus","first-page":"E15","article-title":"A quantitative analysis of craniopharyngioma cyst expansion during and after radiation therapy and surgical implications","volume":"41","author":"Lamiman K","year":"2016","unstructured":"Lamiman K, Wong KK, Tamrazi B,  A quantitative analysis of craniopharyngioma cyst expansion during and after radiation therapy and surgical implications. Neurosurg Focus. 2016;41(6):E15. doi:10.3171\/2016.9.FOCUS16298"},{"issue":"6","key":"b15","series-title":"BMJ Open","first-page":"e046043","article-title":"Proton therapy for craniopharyngioma in adults: a protocol for systematic review and meta-analysis","volume":"11","author":"Li P","year":"2021","unstructured":"Li P, Wang J, Axier A,  Proton therapy for craniopharyngioma in adults: a protocol for systematic review and meta-analysis. BMJ Open. 2021;11(6):e046043. doi:10.1136\/bmjopen-2020-046043"},{"issue":"11","key":"b16","series-title":"AJNR Am J Neuroradiol","first-page":"2073","article-title":"Topographic diagnosis of craniopharyngiomas: the accuracy of MRI findings observed on conventional T1 and T2 images","volume":"38","author":"Prieto R","year":"2017","unstructured":"Prieto R, Pascual JM, Barrios L. Topographic diagnosis of craniopharyngiomas: the accuracy of MRI findings observed on conventional T1 and T2 images. AJNR Am J Neuroradiol. 2017;38(11):2073\u20132080. doi:10.3174\/ajnr.A5361"},{"issue":"2","key":"b17","series-title":"Neurosurgery","first-page":"204","article-title":"A clinical rule for preoperative prediction of BRAF mutation status in craniopharyngiomas","volume":"85","author":"Fujio S","year":"2019","unstructured":"Fujio S, Juratli TA, Arita K,  A clinical rule for preoperative prediction of BRAF mutation status in craniopharyngiomas. Neurosurgery. 2019;85(2):204\u2013210. doi:10.1093\/neuros\/nyy569"},{"issue":"5","key":"b18","series-title":"J Neuropathol Exp Neurol","first-page":"330","article-title":"Basal recess in third ventricle tumors: a pathological feature defining a clinical-topographical subpopulation of papillary craniopharyngiomas","volume":"81","author":"Pascual JM","year":"2022","unstructured":"Pascual JM, Prieto R, Carrasco R, Barrios L. Basal recess in third ventricle tumors: a pathological feature defining a clinical-topographical subpopulation of papillary craniopharyngiomas. J Neuropathol Exp Neurol. 2022;81(5):330\u2013343. doi:10.1093\/jnen\/nlac020"},{"issue":"9","key":"b19","series-title":"AJNR Am J Neuroradiol","first-page":"1333","article-title":"Duct-like recess in the infundibular portion of third ventricle craniopharyngiomas: an MRI sign identifying the papillary type","volume":"43","author":"Pascual JM","year":"2022","unstructured":"Pascual JM, Carrasco R, Barrios L, Prieto R. Duct-like recess in the infundibular portion of third ventricle craniopharyngiomas: an MRI sign identifying the papillary type. AJNR Am J Neuroradiol. 2022;43(9):1333\u20131340. doi:10.3174\/ajnr.A7602"},{"issue":"2","key":"b20","series-title":"J Neurosurg","first-page":"381","article-title":"Displacement of mammillary bodies by craniopharyngiomas involving the third ventricle: surgical-MRI correlation and use in topographical diagnosis","volume":"119","author":"Pascual JM","year":"2013","unstructured":"Pascual JM, Prieto R, Carrasco R, Barrios L. Displacement of mammillary bodies by craniopharyngiomas involving the third ventricle: surgical-MRI correlation and use in topographical diagnosis. J Neurosurg. 2013;119(2):381\u2013405. doi:10.3171\/2013.1.JNS111722"},{"issue":"5","key":"b21","series-title":"Jpn J Clin Oncol","first-page":"378","article-title":"Optic tract edema in craniopharyngioma as a predictor of BRAFV600E mutation presence","volume":"53","author":"Taguchi A","year":"2023","unstructured":"Taguchi A, Kinoshita Y, Kojima M,  Optic tract edema in craniopharyngioma as a predictor of BRAFV600E mutation presence. Jpn J Clin Oncol. 2023;53(5):378\u2013385. doi:10.1093\/jjco\/hyad003"},{"issue":"3","key":"b22","series-title":"Clin Nucl Med","first-page":"245","article-title":"High 18F-FDG uptake in a papillary craniopharyngioma of the third ventricle","volume":"48","author":"Kaida H","year":"2023","unstructured":"Kaida H, Matsukubo Y, Im SW, Kashiwagi N, Ishii K. High 18F-FDG uptake in a papillary craniopharyngioma of the third ventricle. Clin Nucl Med. 2023;48(3):245\u2013247. doi:10.1097\/RLU.0000000000004562"},{"key":"b23","series-title":"World Neurosurg","first-page":"591","article-title":"Preoperative evaluation of sellar and parasellar macrolesions by [18F]fluorodeoxyglucose positron emission tomography","volume":"103","author":"Tosaka M","year":"2017","unstructured":"Tosaka M, Higuchi T, Horiguchi K,  Preoperative evaluation of sellar and parasellar macrolesions by [18F]fluorodeoxyglucose positron emission tomography. World Neurosurg. 2017;103:591\u2013599. doi:10.1016\/j.wneu.2017.04.032"},{"issue":"1","key":"b24","series-title":"BMC Neurol","first-page":"6","article-title":"Noninvasive molecular diagnosis of craniopharyngioma with MRI-based radiomics approach","volume":"19","author":"Chen X","year":"2019","unstructured":"Chen X, Tong Y, Shi Z,  Noninvasive molecular diagnosis of craniopharyngioma with MRI-based radiomics approach. BMC Neurol. 2019;19(1):6. doi:10.1186\/s12883-018-1216-z"},{"issue":"1","key":"b25","series-title":"Radiat Oncol","first-page":"161","article-title":"Proton beam therapy for craniopharyngioma: a systematic review and meta-analysis","volume":"19","author":"Li Z","year":"2024","unstructured":"Li Z, Li Q, Tian H,  Proton beam therapy for craniopharyngioma: a systematic review and meta-analysis. Radiat Oncol. 2024;19(1):161. doi:10.1186\/s13014-024-02556-w"},{"issue":"5","key":"b26","series-title":"Pituitary","first-page":"103","article-title":"Efficacy and safety of proton therapy and photon therapy for patients with craniopharyngioma: a systematic review and meta-analysis","volume":"28","author":"Pan LS","year":"2025","unstructured":"Pan LS, Zhang J, Xiong YT, Zhan JB, Wang QY, Hong T. Efficacy and safety of proton therapy and photon therapy for patients with craniopharyngioma: a systematic review and meta-analysis. Pituitary. 2025;28(5):103. doi:10.1007\/s11102-025-01578-1"},{"issue":"5","key":"b27","series-title":"Nat Med","first-page":"1103","article-title":"Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial","volume":"29","author":"Subbiah V","year":"2023","unstructured":"Subbiah V, Kreitman RJ, Wainberg ZA,  Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial. Nat Med. 2023;29(5):1103\u20131112. doi:10.1038\/s41591-023-02321-8"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/60\/6\/article-pE13.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/60\/6\/article-pE13.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/60\/6\/article-pE13.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:32Z","timestamp":1780444832000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/60\/6\/article-pE13.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":54,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2026.2.focus251155","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}